|
HS Code |
352015 |
| Productname | N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide |
| Casnumber | 1453089-65-0 |
| Molecularformula | C13H18BNO3 |
| Molecularweight | 247.10 |
| Appearance | White to off-white solid |
| Purity | Typically ≥ 97% |
| Solubility | Soluble in organic solvents such as DMSO and dichloromethane |
| Smiles | B1OC(C)(C)C(C)(C)O1c2cccc(NC=O)c2 |
| Inchi | InChI=1S/C13H18BNO3/c1-13(2)17-12(18-13)14-10-6-5-8-11(7-10)15-9-16/h5-9,12H,1-2H3,(H,15,16) |
| Storagecondition | Store at 2-8°C, protected from light and moisture |
| Synonyms | 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)aniline formamide |
As an accredited N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 25g of N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide is supplied in a sealed amber glass bottle with hazard labeling. |
| Shipping | N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide ships in sealed, chemical-resistant containers, protected from moisture and light. During transit, temperature should be kept at ambient levels, away from incompatible substances. Ensure labeling complies with relevant hazardous material regulations, and package securely to prevent leaks or breakage. Safety Data Sheet (SDS) accompanies each shipment. |
| Storage | Store **N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide** in a tightly sealed container in a cool, dry, well-ventilated area, away from heat, moisture, and incompatible substances such as strong oxidizers. Protect from direct sunlight. Always handle under an inert atmosphere, such as nitrogen or argon, to prevent hydrolysis and ensure chemical stability. Follow all relevant safety protocols. |
Applications of N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide in Industrial ManufacturingAs a direct manufacturer of N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide, we focus our production and supply on several advanced industrial verticals that demand precise molecular intermediates for high-value synthesis. The following sections outline specific downstream fields utilizing this compound, each broken down by regulatory environment, usage ratio, process context, and finished product type. 1. Pharmaceutical API Synthesis – Suzuki–Miyaura Coupling IntermediateMajor pharmaceutical companies and third-party manufacturers use our material as a key boronic ester intermediate during the Suzuki–Miyaura cross-coupling process. This enables introduction of phenylboronate moieties into drug candidates for oncology, CNS, and anti-viral APIs. Formamide substitution on the aromatic ring supports increased specificity and improved downstream reaction yield in select heterocyclic scaffolds. Customers process large-scale campaigns in multipurpose reactors under validated GMP controls for regulated markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Synthesis – Herbicide and Fungicide IntermediateLeading crop protection manufacturers incorporate this compound as a tailored boron-based building block for synthesizing selective herbicides and systemic fungicides. Its structure supports efficient transfer of aryl groups into active molecules, increasing crop targeting accuracy and bioavailability. Quality control laboratories test trace impurities through GC and HPLC during the technical phase before formulation and field trial batches. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Electronic Materials – OLED and Organic Semiconductor PrecursorAdvanced electronic device manufacturers select this boron-containing compound for constructing donor–acceptor structures in organic semiconductors and OLED emitter layers. The compound’s stability and the presence of the tetramethyldioxaborolane group facilitate controllable cross-coupling chemistry, allowing high-yield formation of conjugated materials needed for display and lighting technologies. Production environments typically require solvent purity traceability and sub-ppm metal analysis before integration into device fabrication. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Specialty Chemical Synthesis – Cross-Coupling Reagent for Dye and Pigment ManufacturingDye and pigment manufacturers rely on the boron-substituted aromatic backbone of this compound to create specialty chromophores. Its use enables high fidelity in Suzuki-based aromatic coupling, crucial for producing colorants with advanced photostability and chemical resistance properties. Colorant synthesis involves multi-stage production under strict process documentation to ensure batch reproducibility and regulatory compliance for use in industrial inks and coatings. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive N-[3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl]Formamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Across decades in chemical production, we have seen the landscape of organoboron chemistry shift from curiosity to cornerstone technology. Among the range of boron-based intermediates, N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide stands out for its balanced reactivity, shelf stability, and adaptability in both research and scale-up environments. In our facility, we approach the synthesis and purification of this compound with methods designed around consistency and the requirements of advanced coupling chemistry.
With the formal name N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide, chemists usually recognize the standout features in the structure—the robust boronate ester group attached to a phenyl ring, all anchored by a formamide moiety. We produce this compound under tightly controlled conditions, using high-purity starting materials that keep trace metals and residual solvents to a strict minimum. We observe each batch through analytical checks including NMR, LC-MS, and elemental analysis, never cutting corners on documentation. These standards keep downstream users confident in their reactions whether they scale up or optimize routes for medicinal chemistry campaigns.
The rise of boronate esters traces directly to the Suzuki-Miyaura cross-coupling, a staple in every synthetic lab. Our experience with this class of compounds taught us early on to identify the right ligand environment, striking a compromise between air stability and ease of transmetalation. The 4,4,5,5-tetramethyl-1,3,2-dioxaborolane group keeps the boron center protected against hydrolysis but does not interfere in the presence of typical palladium catalysts. This combination lets the compound travel well and store for prolonged periods under the usual refrigerated, dry conditions. Our customers in academic discovery teams and process groups often echo our own findings: minimal degradation means cleaner reactions and fewer side products, cut-down on purification steps, and time saved during route scouting.
We handle N-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide in the same production hall as our other boronates and amide derivatives, but years of process risk assessments showed this molecule offers a practical advantage in reduced dust and manageable volatility. In use, solid-state stability alleviates many of the headaches that come with more sensitive boronic acids and boron trihalides. Environmental engineers on our team mapped out containment and filtration designs that prevent any meaningful loss of boron to waste streams—not every boron building block submits so readily to modern plant management principles. We learned that clean handling starts at precision weighing and systematic washing protocols, and we enforce those steps religiously to guarantee end users receive what they expect, with trace impurities below disclosure thresholds.
The bread and butter for this compound falls within aryl-aryl bond formation. In our experience, medicinal chemists reach for this intermediate to construct diverse biphenyl scaffolds with an eye toward structure-activity relationship studies. By leaving the formamide open for downstream modification—simple hydrolysis or reductive transformations—users keep access to aldehydes, amines, or substituted motifs while retaining the orthogonal handles for further complexity. We watched project teams push their screening plates out with surprising throughput, reporting sharp yields and selectivity in iterative Suzuki–Miyaura couplings. The underlying stability of our batches enabled scale-ups from milligrams to hundreds of grams with no new side reactions or frustrating decomposition, which is not a given for every boronate ester.
We manufacture several boronic and boronate ester derivatives aimed at cross-coupling, and over years of being on the production floor, patterns emerge. Boronic acids suffer from greater instability to air and moisture—shelves sometimes fill with polymers, acids or pinacol hydrolysis products. In contrast, the dioxaborolane ester keeps a handle on reactivity until you add base and catalyst under controlled lab conditions, providing a kind of on-demand activation. The formamide group holds a unique place as well: while methyl, methoxy, or halogen groups on the phenyl ring tweak electronic properties, the formamide offers more chemistry for medicinal efforts, giving medicinal teams plenty of leverage to create libraries or insert molecular diversity.
Our production records show a steady increase in demand for building blocks offering not just reactive boron, but also embedded functionality for further upgrade. The phenyl-formamide backbone in this product means a user can direct next-step reactions such as Vilsmeier–Haack formylation, reductions, or condensation with hydrazines. Instead of returning to the drawing board to install amine or aldehyde handles, users already have multiple routes to diversify molecular backbones starting from the same stable core. Conversations with process development teams reinforce the value of this approach—supply chain managers prefer the predictability of a single, versatile intermediate over juggling a dozen analogues that each need specialized storage and stability assessments.
In the early days of manufacturing N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide, small batches for research used lengthy crystallizations and vacuum-drying steps. Our engineers worked through pilot lots to bring solvent recycling online, tune filtration parameters, and tech transfer those findings to commercial runs of twenty kilograms or more. What surprised us most was the resilience of the compound through scale-up: while so many aryl boronates degrade or caramelize in heated vessels, this one retained appearance and purity at every marker lot. Our control chemists dialed in temperature ramps and protected against hot-spotting—critical where exothermic transformations can escalate quickly. Because of the robust response, customers reported plug-and-play integration into automated synthesis platforms, with minimal process modification needed.
Reliable chemistry starts with known, consistent inputs. Over years of producing this molecule, the most common feedback revolves around batch-to-batch homogeneity. The market offers other boronate esters that skip proper drying, filtration, or storage protections; chemists find themselves fighting unexpected water picks, color changes, or even subvisible particles. Our own experience runs counter to those issues. Each lot undergoes moisture and residual solvent checks by Karl Fischer titration and gas chromatography, and our specifications for boron and nitrogen content apply equally whether we’re shipping one bottle or fifty. That discipline plays out in downstream success—fast, clean reactions, reproducible results, and high recovery in catalyst screenouts.
Compliance teams stay busier now than in years past, thanks to tightening rules around waste-handling, exposure, and impurity profiles—especially in pharmaceutical supports. Our production know-how includes minimizing regulated byproducts and using green chemistry alternatives where possible, such as recycling dioxaborolane sources and reducing solvent consumption. We long ago replaced heavy-metal based drying agents with molecular sieves, and our logs track every drum and flask for cradle-to-gate traceability. During audits, this traceability reassures custom synthesis partners that standards for quality, environmental management, and impurity control remain at the heart of our operation. Comments from QA partners reinforce that transparency makes a difference, especially for high-value linkers and advanced intermediates.
Our typical output covers both research-grade and enhanced purity models. For most synthetic screening, material with standard control on purity and known volatility suits the need. Drug development teams sometimes order higher grade batches, which pass broader screens for polymorph content, particulate analysis, and relevant catalytic metal carryover. Over time, process optimization led us to reduce batch-tied variance in melting point, moisture content, and actual assay measurements, so even our ‘standard’ release meets outlines used by most R&D teams. The differences between our products and bulk-market equivalents run deeper than simple technical paperwork—customer feedback often notes improved NMR clarity, fewer unwanted peaks in HPLC runs, and sharper endpoint profiles during process QA.
The shift towards more complex medicinal R&D demands faster access to well-behaved, modular building blocks. Beyond simple aryl coupling, researchers ask for customizable cores that let them move quickly from hit to lead—with little downtime fighting terminal impurity issues or chasing batches degraded in storage. Our own experience following synthetic projects tells us: offering products like N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide lets experienced chemists plan campaigns with more confidence. They can afford to focus on discovery, not navigating new purity profiles, rechecking moisture content, or swapping out key coupling partners mid-flow.
From pilot trials through multi-year shelf studies, we tracked key stability drivers under ambient and controlled conditions. The compound’s resistance to airborne moisture and gradual yellowing impressed storage managers and research users alike. Even after prolonged holding, analytical review kept showing tight retention of functional group integrity and no significant uptick in trace degradants. By using desiccated storage with light protection, customers maximize the working lifetime; our own years-long archives prove this point, with test samples paused and resumed across multiple campaigns without sudden surprises.
Modern workflows in pharma and agrochemical discovery need intermediates that can handle high-throughput screening and parallel synthesis. This product’s compatibility with liquid handling and robotic work-up fits the automation now common in leading labs. Customers using integrated analytical tools report less baseline drift and fewer instrument alerts tied to the boronate region. Clean conversion, minimal carryover, crisp workup—these features support the wider goal of rapidly populating compound libraries and exploring SAR without logistical headaches at the coupling stage. Our team watches orders come through from groups trialing whole panels of analogs, spreading combinatorial chemistry far beyond what the earliest boronic acids could support.
Attention now shifts not just to what products deliver in the flask, but how they fit into broader environmental and sustainability frameworks. Improved atom economy, reduced waste, and minimization of hazardous byproduct flow through every part of our process evaluation. Like other boron-based intermediates, this formamide boronate can be recycled from filtrates, and downstream hydrolysis routes can lessen overall boron residues compared with less selective alternatives. By investing in upstream analytics, we catch impurities long before shipping, avoid complex corrections downstream, and save both raw material and operator time—a lesson learned hard but well over years in production.
Our approach to manufacturing this compound grew straight from dialogue with process chemists and researchers who use the material most. Requests for tighter moisture limits, more robust shipment packaging, and explicit documentation on trace elements moved us to update both the plant floor and the logistics arm. Translated into action, these lessons show up in double-sealed drums, clearer batch tracking, and direct lines to our technical team. When someone flags an outlier or an atypical reaction, we investigate and adapt. That’s a level of responsiveness only gained by staying rooted in the practicalities of daily use, not just technical brochures.
Chemists new to organoboron chemistry always appreciate real routes and work-up notes, not just catalog numbers and purity specs. We support customers with guidance rooted in dozens of successful transfer projects, sharing reputable published precedent and firsthand observations. For N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide, our in-house notebooks capture optimized conditions for Suzuki coupling, amide deprotection, and selective alkylation. Tracking temperature, solvent, and catalytic systems gives users a head start, saving trial-and-error cycles and helping troubleshoot if a wall shows up during process transfer.
Over years of firsthand production, N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]formamide earned its place in our stable of reliable, effective building blocks. It let us respond to both custom chemistry and demanding regulatory environments while pushing the boundary on shelf life and analytical purity. Users rely on its predictable performance, both for routine medicinal chemistry and for more ambitious, multi-step synthetic routes. Our faith rests on practical observations—by focusing on quality, documentation, and continual process adjustment, we keep pace with evolving applications and raised expectations from our most exacting research and process partners.